IBB ETF holdings (NASDAQ) - Page 10 | MetaTrader

Apri il grafico completo

Panoramica Tutti gli asset Mappa di calore

Principali partecipazioni Market Value Shares Weight %

PACB Pacific Biosciences of California, Inc. 3.35 M 2.00 M 0.04%

CCCC C4 Therapeutics, Inc. 3.30 M 707.43 K 0.04%

AURA Aura Biosciences, Inc. 3.24 M 455.97 K 0.04%

SGMT Sagimet Biosciences, Inc. 3.20 M 413.33 K 0.04%

ARVN Arvinas, Inc. 3.19 M 383.62 K 0.04%

CABA Cabaletta Bio, Inc. 3.13 M 1.01 M 0.03%

PRTA Prothena Corp. plc 3.12 M 318.88 K 0.03%

ALVO Alvotech SA 3.10 M 838.98 K 0.03%

EBS Emergent BioSolutions, Inc. 2.88 M 343.57 K 0.03%

ENTA Enanta Pharmaceuticals, Inc. 2.84 M 194.70 K 0.03%

NGNE Neurogene, Inc. 2.78 M 88.40 K 0.03%

FLGT Fulgent Genetics, Inc. 2.65 M 128.92 K 0.03%

RCKT Rocket Pharmaceuticals, Inc. 2.50 M 730.40 K 0.03%

PRME Prime Medicine, Inc. 2.47 M 670.02 K 0.03%

VNDA Vanda Pharmaceuticals, Inc. 2.46 M 402.51 K 0.03%

KYTX Kyverna Therapeutics, Inc. 2.37 M 266.21 K 0.03%

BBOT BridgeBio Oncology Therapeutics, Inc. 2.33 M 306.02 K 0.03%

TECX Tectonic Therapeutic, Inc. 2.29 M 66.55 K 0.03%

AUTL Autolus Therapeutics plc 2.29 M 1.43 M 0.03%

EDIT Editas Medicine, Inc. 2.23 M 687.47 K 0.02%

1
...
6
7
8
9
10
11
12
13

Notizie

UBS elenca 5 motivi chiave per cui le azioni biotech a media capitalizzazione dovrebbero performare bene nel 2026